Published in Biopolymers on January 01, 2011
Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem (1970) 8.87
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther (2003) 3.48
Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats. Psychopharmacology (Berl) (2005) 2.60
[Cyclosporin A, a Peptide Metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity]. Helv Chim Acta (1976) 2.58
Specific receptor for the opioid peptide dynorphin: structure--activity relationships. Proc Natl Acad Sci U S A (1981) 2.53
Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs (1993) 1.69
Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn. Eur J Pharmacol (2007) 1.56
Detection of secondary amines on solid phase. Pept Res (1996) 1.52
An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence. J Subst Abuse Treat (2000) 1.37
Solid-phase synthesis and characterization of N-methyl-rich peptides. J Pept Res (2005) 1.31
Optimized selective N-methylation of peptides on solid support. J Pept Sci (2006) 1.18
Identification of arodyn, a novel acetylated dynorphin A-(1-11) analogue, as a kappa opioid receptor antagonist. J Med Chem (2002) 1.07
N-methylated cyclic pentaalanine peptides as template structures. J Am Chem Soc (2006) 1.01
Effects of JDTic, a selective kappa-opioid receptor antagonist, on the development and expression of physical dependence on morphine using a rat continuous-infusion model. Eur J Pharmacol (2005) 0.99
Effect of N-methyl substitution of the peptide bonds in luteinizing hormone-releasing hormone agonists. J Med Chem (1993) 0.94
Involvement of the opioid system in the anxiolytic effect of diazepam in mice. Eur J Pharmacol (1996) 0.91
The effects of isolated N-methylated residues on the conformational characteristics of polypeptides. Biopolymers (1976) 0.91
Design of a potent combined pseudopeptide endothelin-A/endothelin-B receptor antagonist, Ac-DBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21 (PD 156252): examination of its pharmacokinetic and spectral properties. J Med Chem (1997) 0.86
The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide. Neuropharmacology (1998) 0.85
Structure-activity relationships of arodyn, a novel acetylated kappa opioid receptor antagonist. J Pept Res (2005) 0.85
Cis/trans conformational equilibrium across the N-methylphenylalanine- N-methylphenylalanine peptide bond of arginine vasopressin analogs. J Pept Res (2004) 0.84
Bradykinin analogues containing N alpha-methyl amino acids. J Med Chem (1980) 0.83
Kinetic investigation of the effect of the amino acid side chains in the selective acidolysis of N-acyl-N,alpha,alpha-trialkyl glycine amides. J Pept Sci (2005) 0.78
Effect of temperature on the acidolysis of N-acyl-N,alpha,alpha-trialkyl glycine amides as related to the nature of substituents. J Pept Sci (2006) 0.77
Kinetic and mechanistic investigation of the selective acidolysis of the C-terminal amide bond of N-acyl-N,alpha,alpha-trialkyl glycine amides. J Pept Sci (2005) 0.77
Pathobiology of dynorphins in trauma and disease. Front Biosci (2005) 1.17
Identification of arodyn, a novel acetylated dynorphin A-(1-11) analogue, as a kappa opioid receptor antagonist. J Med Chem (2002) 1.07
[Nalpha-benzylTyr1,cyclo(D-Asp5,Dap8)]- dynorphin A-(1-11)NH2 cyclized in the "address" domain is a novel kappa-opioid receptor antagonist. J Med Chem (2005) 1.02
Novel opioid cyclic tetrapeptides: Trp isomers of CJ-15,208 exhibit distinct opioid receptor agonism and short-acting κ opioid receptor antagonism. Br J Pharmacol (2012) 0.95
A solid-phase synthetic strategy for labeled peptides: synthesis of a biotinylated derivative of the delta opioid receptor antagonist TIPP (Tyr-Tic-Phe-Phe-OH). Org Lett (2003) 0.90
The macrocyclic tetrapeptide [D-Trp]CJ-15,208 produces short-acting κ opioid receptor antagonism in the CNS after oral administration. Br J Pharmacol (2013) 0.89
Translocation of dynorphin neuropeptides across the plasma membrane. A putative mechanism of signal transmission. J Biol Chem (2005) 0.89
Synthesis of cyclic tetrapeptide CJ 15,208: a novel kappa opioid receptor antagonist. Adv Exp Med Biol (2009) 0.89
Targeting inhibitor 2 of protein phosphatase 2A as a therapeutic strategy for prostate cancer treatment. Cancer Biol Ther (2013) 0.89
Synthesis of CJ-15,208, a novel κ-opioid receptor antagonist. Tetrahedron Lett (2010) 0.88
Involvement of dynorphin and kappa opioid receptor in yohimbine-induced reinstatement of heroin seeking in rats. Synapse (2013) 0.86
A novel N-terminal cyclic dynorphin A analogue cyclo(N,5)[Trp(3),Trp(4),Glu(5)] dynorphin A-(1-11)NH(2) that lacks the basic N-terminus. J Med Chem (2003) 0.86
Analytical and biological methods for probing the blood-brain barrier. Annu Rev Anal Chem (Palo Alto Calif) (2012) 0.86
The effects of C-terminal modifications on the opioid activity of [N-benzylTyr(1)]dynorphin A-(1-11) analogues. J Med Chem (2009) 0.84
Solid phase synthesis and evaluation of Tyr-Tic-Phe-Phe(p-NHCOCH(2)Br) ([Phe(p-bromoacetamide)(4)]TIPP), a potent affinity label for delta opioid receptors. J Med Chem (2002) 0.80
The permeation of dynorphin A 1-6 across the blood brain barrier and its effect on bovine brain microvessel endothelial cell monolayer permeability. Peptides (2012) 0.78
Discovery of dermorphin-based affinity labels with subnanomolar affinity for mu opioid receptors. J Med Chem (2009) 0.78
κ-Opioid receptor inhibition of calcium oscillations in spinal cord neurons. Mol Pharmacol (2011) 0.77
Synthesis and evaluation of derivatives of leucine enkephalin as potential affinity labels for delta opioid receptors. Biopolymers (2003) 0.77
The synthesis of DAMGO-based potential affinity labels with high mu opioid receptor affinity and the formation of cyclic O-alkyl thiocarbamates. Adv Exp Med Biol (2009) 0.77
Design, synthesis, and pharmacological activities of dynorphin A analogues cyclized by ring-closing metathesis. J Med Chem (2009) 0.77
Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3. J Med Chem (2004) 0.76
High affinity conformationally constrained nociceptin/orphanin FQ(1-13) amide analogues. J Med Chem (2008) 0.76
Deletion of Ac-NMePhe(1) from [NMePhe(1) ]arodyn under acidic conditions, part 2: effects of substitutions on pharmacological activity. Biopolymers (2011) 0.75
A convenient approach to synthesizing peptide C-terminal N-alkyl amides. Biopolymers (2011) 0.75
Synthesis of novel basic head-to-side-chain cyclic dynorphin A analogs: strategies and side reactions. Biopolymers (2003) 0.75
Design and synthesis of cyclic arodyn analogues by ring-closing metathesis (RCM) for kappa opioid receptor (KOP) antagonists. Adv Exp Med Biol (2009) 0.75
Solid phase and solution synthesis of NvocLys(CO(CH2)5NH-NBD)OCH2CN, a trifunctional fluorescent lysine derivative. Amino Acids (2008) 0.75
Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2. J Med Chem (2003) 0.75